Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

BCS
Home/The Filing Wire/LIFECORE BIOMEDICAL, INC. \DE\/ DEFA14A

SEC Filing · DEFA14A

LIFECORE BIOMEDICAL, INC. \DE\

LFCRNASDAQEQUITYCurrent

SEC Filing

Filed Sep 28, 2026Accepted Sep 28, 2026, 8:56 AM EDTCIK 1005286Accession 0001140361-26-037768
View company →Permanent SEC source ↗
Share

Company context

Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com. The contents of Lifecore’s website are not incorporated by reference into this press release.

Current securities

LFCRNASDAQ · EQUITY · Current

Recent company filings

  1. Entry into a Material Definitive AgreementSep 29, 2026
  2. Entry into a Material Definitive Agreement · Regulation FD DisclosureSep 28, 2026
  3. 10-Q filingAug 5, 2026
  4. Results of Operations and Financial Condition · Regulation FD DisclosureAug 5, 2026
  5. SCHEDULE 13G filingJul 29, 2026

As-filed source

Primary evidence
As filedOpen full document ↗

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.